Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
about
Two classifiers based on serum peptide pattern for prediction of HBV-induced liver cirrhosis using MALDI-TOF MS.Differential protein expression and peak selection in mass spectrometry data by binary discriminant analysis.Sparse Proteomics Analysis - a compressed sensing-based approach for feature selection and classification of high-dimensional proteomics mass spectrometry dataCirculating proteolytic products of carboxypeptidase N for early detection of breast cancerProteomics in pancreatic cancer research.Fatty acid and peptide profiles in plasma membrane and membrane rafts of PUFA supplemented RAW264.7 macrophages.The Use of Principal Component Analysis in MALDI-TOF MS: a Powerful Tool for Establishing a Mini-optimized Proteomic ProfileSerum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinomaPotential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches.MALDIquant: a versatile R package for the analysis of mass spectrometry data.Analysis of the differentially expressed low molecular weight peptides in human serum via an N-terminal isotope labeling technique combining nano-liquid chromatography/matrix-assisted laser desorption/ionization mass spectrometry.Deciphering the ovarian cancer ascites fluid peptidome.Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancerPlasma peptidome profiling of acute hepatitis E patients by MALDI-TOF/TOF.Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma.Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.Serum amino acid profiles and their alterations in colorectal cancer.Clinical peptidomic analysis by a one-step direct transfer technology: its potential utility for monitoring of pathophysiological status in female reproductive system disorders.Serum peptidomic profiling identifies a minimal residual disease detection and prognostic biomarker for patients with acute leukemia.Plasma peptide biomarker discovery for amyotrophic lateral sclerosis by MALDI-TOF mass spectrometry profilingInvestigation of Pokemon-regulated proteins in hepatocellular carcinoma using mass spectrometry-based multiplex quantitative proteomics.Plasma metabolite biomarkers for the detection of pancreatic cancerSerum peptide pattern that differentially diagnoses hepatitis B virus-related hepatocellular carcinoma from liver cirrhosis.Rapid Detection of Vancomycin-Intermediate Staphylococcus aureus by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.Seven-signal proteomic signature for detection of operable pancreatic ductal adenocarcinoma and their discrimination from autoimmune pancreatitis.The Role of Cytokine PF4 in the Antiviral Immune Response of Shrimp.Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models.Serum biomarkers identification by mass spectrometry in high-mortality tumors.CXCL4 mediates tumor regrowth after chemotherapy by suppression of antitumor immunitySerum dihydroxyacetone kinase peptide m/z 520.3 as predictor of disease severity in patients with compensated chronic hepatitis B.Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling.Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.A roadmap for successful applications of clinical proteomics.Screening technologies for target identification in pancreatic cancer.Potential for proteomic approaches in determining efficacy biomarkers following administration of fish oils rich in omega-3 fatty acids: application in pancreatic cancers.Pancreatic carcinoma, pancreatitis, and healthy controls: metabolite models in a three-class diagnostic dilemma.Proteome-based biomarkers in pancreatic cancer.Proteins and Proteoforms: New Separation Challenges.Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.Mean platelet volume predicts survival in pancreatic cancer patients with synchronous liver metastases.
P2860
Q30456214-C88C6427-4084-4504-B3EB-704184BF0CA4Q30961630-845E7FA0-071D-4A42-B8AE-568AB5DE06FCQ31172638-D9756511-D973-43BB-BF6E-880FA6A76124Q33685829-3B3CFC40-C3BD-4CA8-ACB0-0F5146A69123Q33791981-93AD9511-2828-4E7F-B32B-9E4391A7B06CQ34009834-BC20A7E1-95C4-433A-B6D4-BE83C2974573Q34121793-511B70EC-C37D-4E2A-9775-1E0813EFCD77Q34185657-3609D336-B447-4CC7-9265-9DCA1AE39D63Q34305848-7F4F96D7-489D-4A70-B00D-F47129736A76Q34337857-D1C47032-A366-4A77-9897-7772A347B340Q34420715-CEB064E3-59B3-48C3-A7D9-C08A64D22313Q34501478-C69551CA-93D0-45E0-965D-747A6BE61752Q34532251-0ECC4B4C-7320-4557-8E27-150025FBC08DQ34589499-9CC2AAA0-97F4-415C-AA67-33A3D3F4D4E1Q34644418-6E98086D-8B7E-472C-BBAE-85940CD574BBQ34657038-B629B576-E5C0-40A4-90DE-A9E4FE95B94BQ34660782-A035A03C-C87E-4DBE-B2D3-739986D1F93DQ34986725-F53010FF-3A60-4151-A046-83A8BD48A980Q35030141-F70D82DC-6AAD-4F00-9EB1-2A7A624DA006Q35041471-5D909514-75A8-4A99-B2E8-EEEF7E45F28CQ35049696-903F9273-9D4E-41B0-ACBF-4C58F2CDE94CQ35072866-F3D1297C-3908-4EE8-9372-0724E7C6884DQ35115406-BEFA18F1-86D6-4C07-AA47-CD13A3E5BE19Q35893439-524B352F-20F5-46E7-8AEC-78C3A792617EQ35990884-E6CBCF13-8239-43D1-8F24-240D1A69BDB9Q36133772-58705224-BC3F-466C-89FD-104DC7749916Q36443870-0111D371-15EA-40FD-A7CE-B07052487FFAQ36582422-8C1E04A2-8C36-4321-AE7B-613632ADC858Q36843770-8A027EFE-64BD-4A9C-8D01-3F372B7FAD93Q37364800-8289B57E-2301-40E3-8E5E-51E4F95912CAQ37582071-6439A199-FB44-4949-B8BF-8DD99A9FA2CBQ37824829-E43A2BE0-E7B0-41E5-9EA8-947F8846B2E5Q37869461-FB1FEA00-0634-4821-AA1E-28A3BF62E3A5Q38161327-7CA8C20A-6625-48D8-BE0A-718E0A66E09AQ38330381-7EC233EC-198B-46E9-9A18-C65C6C2BC442Q40634575-DDCD789D-6AEB-48A4-9435-625566C146B8Q43008803-8E9B16C3-970A-4EDE-927B-44023F021C6DQ47328337-AAA7B993-8897-461E-99E3-6E1E352CEA3CQ49701167-A89F86F2-7B43-42D7-B9BE-CA73973DC957Q55228708-9DE5239B-E6D1-40C6-A064-BBB731155E8B
P2860
Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Serum peptidome profiling reve ...... ciated with pancreatic cancer.
@ast
Serum peptidome profiling reve ...... ciated with pancreatic cancer.
@en
type
label
Serum peptidome profiling reve ...... ciated with pancreatic cancer.
@ast
Serum peptidome profiling reve ...... ciated with pancreatic cancer.
@en
prefLabel
Serum peptidome profiling reve ...... ciated with pancreatic cancer.
@ast
Serum peptidome profiling reve ...... ciated with pancreatic cancer.
@en
P2093
P50
P1476
Serum peptidome profiling reve ...... ciated with pancreatic cancer.
@en
P2093
Arved Weimann
Christof Schütte
Helmut Witzigmann
Johann Hauss
Julia Kase
Klaus Felix
P304
P356
10.1158/1078-0432.CCR-08-2701
P407
P50
P577
2009-05-26T00:00:00Z